Mechanism Underlying Multidrug Resistance
A team of researchers led by Anders Näär, PhD, of the Massachusetts General Hospital (MGH) Cancer Center has identified a mechanism controlling multidrug resistance in fungi. This discovery could help advance treatments for the opportunistic fungal infections that often plague individuals with compromised immunity, such as patients receiving chemotherapy, transplant recipients treated with immunosuppressive drugs, and AIDS patients. Read More >

The Pancreatic Cancer Action Network Awards Pilot Grant to Cancer Researcher

Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal of cancers and is often resistant to chemotherapy.

Nabeel Bardeesy, PhD, Pilot Grant Award winner, focus is to compare drug sensitivity with the genetic features of pancreatic tumors.

The study is expected to distinguish subgroups of PDAC, provide new insights into effective cancer therapeutics, and lead to more patient specific clinical trials. Read More >

The 2008 Pilot Grant is in honor of Carnegie Mellon University Professor, Dr. Randy Pausch.  Pausch who is terminally ill with pancreatic cancer has dedicated his days to the awareness and education of this disease. The Pilot Grant is co-sponsored by the American Association of Cancer Research.